APLM logo
APLM NASDAQ US

Apollomics Inc. - Class A Ordinary Shares

Healthcare · Biotechnology Website · IPO Nov 2021
$14.72
▲ +$0.00 (+0.00%)
2
Quality Score
fail
Mkt Cap
$20.6M
ROE
-688.3%
D/E
19.96
Beta
1.63
52W
$4–$42

Wall Street Consensus

7 analysts · Dec 2024
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2024-12-31 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -688.3% -688.3% -693.9% -693.9% -693.9% -688.3%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 19.96 19.96 19.86 19.86 19.86 19.96
Current Ratio 1.35 1.35 1.39 1.39 1.39 1.35

Key Ratios

ROA (TTM)
-370.8%
P/B
2.3
EPS (TTM)
$-90.18
CF/Share
$-0.02
52W High
$42.12
52W Low
$3.66
$3.66 52-Week Range $42.12

How does APLM compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

APLM AAPG ABEO ABOS ABP

APLM valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.3
▼ 8% below peers (2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

APLM profitability vs Biotechnology peers

ROE
-688.3%
▼ 923% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-370.8%
▼ 694% below peers (-46.7%)
vs Peers
vs Industry
Weak

APLM financial health vs Biotechnology peers

D/E ratio
20.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
1.4
▼ 70% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.6
▲ 68% above peers (1.0)
vs Peers
vs Industry
More volatile

APLM fundamentals radar

APLM Peer median Industry

APLM profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

APLM vs peers: key metrics

Latest News

No related news yet